Beta-Blockers as First Line Treatment of Hypertension: A Proponent's View

Publisher： Bentham Science Publishers

E-ISSN： 1875-6506|3|1|21-28

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.3, Iss.1, 2007-02, pp. : 21-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 15-20

Bentham Science Publishers

Access to resources Recommend Favorite

Current Place of Beta-Blockers in the Treatment of Hypertension

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 733-741

Bentham Science Publishers

Access to resources Recommend Favorite

Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review

By  

Current Diabetes Reviews, Vol. 6, Iss. 4, 2010-07 ,pp. : 215-221

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Rationale for the Use of Beta-Blockers in the Treatment of Heart Failure: Special Issue: An Overview of Beta-Blockers and Heart Failure (Guest Editor: Syed M. Jafri)

By Sabbah Hani N.  

Heart Failure Reviews, Vol. 9, Iss. 2, 2004-04 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite